MethylPREDNISolone Acetate Injectable Suspension USP 400 mg/10mL (40mg/mL), 10 m Supply Disruption — Teva Pharmaceuticals USA (Mod
MethylPREDNISolone Acetate Injectable Suspension USP 400 mg/10mL (40mg/mL), 10 m Supply Disruption — Teva Pharmaceuticals USA (Mod is one of 9,000 drug supply records in the DrugSupply dataset. Key details — Drug name: MethylPREDNISolone Acetate Injectable Suspension USP 400 mg/10mL (40mg/mL), 10 m; Manufacturer: Teva
| Drug name | MethylPREDNISolone Acetate Injectable Suspension USP 400 mg/10mL (40mg/mL), 10 m |
|---|---|
| Manufacturer | Teva Pharmaceuticals USA |
| Recall/Disruption reason | Lack of Assurance of Sterility |
| Risk classification | Moderate Risk — Temporary Health Consequence |
| Status | Terminated |
| Record type | Enforcement/Recall |
| Recall number | D-0370-2022 |
| Initiation date | 20211231 |
| Quantity affected | 7,400 cartons |
| Dosage form | Drugs |
🔍 Search all drug supply records →
$1199/mo
Try DrugSupply →